Close Menu

NEW YORK (GenomeWeb News) – Sage Labs said today it has entered into a partnership and licensing agreement that provides it access to Caribou Biosciences' intellectual property related to the CRISPR/Cas9 genome editing system.

As part of the deal, Sage will have exclusive rights to Caribou's IP to produce and sell genetically engineered rats. It also gains non-exclusive rights for mouse and rabbit models.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.